SR-Registration Study 1, ROW: Efficacy and Safety of Seroquel® in the Treatment of Patients With Schizophrenia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
The purpose of this 6-week study is to determine whether treatment with Seroquel® Sustained Release (SR) is more effective than placebo in the treatment of acute schizophrenia. PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.
Epistemonikos ID: 19ac7f875c9413f5fb698589e70479ea3e78abac
First added on: May 04, 2024